📊 SONX Key Takeaways
Is Sonendo, Inc. (SONX) a Good Investment?
Sonendo operates with severely negative fundamentals, losing $28M annually on $33.2M revenue while burning $24.8M in cash from operations, implying only ~5 months of runway at current burn rates. Despite a reasonable 35.7% gross margin indicating viable product economics, the company carries unsustainable operational and overhead costs alongside high leverage of 2.78x debt/equity, creating existential financial stress.
Why Buy Sonendo, Inc. Stock? SONX Key Strengths
- Gross margin of 35.7% indicates underlying product viability and market demand
- Revenue growth of 4.7% YoY demonstrates continued customer adoption despite losses
- Cash position of $10.2M provides near-term operational continuity
SONX Stock Risks: Sonendo, Inc. Investment Risks
- Operating losses of $29.4M on $33.2M revenue reveal severe operational inefficiency and unsustainable cost structure
- Negative operating cash flow of -$24.7M with estimated 5-month cash runway at current burn rate
- High debt/equity ratio of 2.78x with $14.4M long-term debt relative to $5.2M equity creates refinancing risk
- Quick ratio of 0.88x indicates near-term liquidity vulnerability
- Zero insider activity in 90 days suggests lack of management confidence in turnaround
Key Metrics to Watch
- Monthly operating cash burn rate and path to positive operating cash flow
- Operating expense reduction initiatives and timeline to operating profitability
- Debt covenant compliance and refinancing capacity
- Revenue growth acceleration needed to justify operational footprint
Sonendo, Inc. (SONX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Sonendo, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
SONX Profit Margin, ROE & Profitability Analysis
SONX vs Healthcare Sector: How Sonendo, Inc. Compares
How Sonendo, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Sonendo, Inc. Stock Overvalued? SONX Valuation Analysis 2026
Based on fundamental analysis, Sonendo, Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Sonendo, Inc. Balance Sheet: SONX Debt, Cash & Liquidity
SONX Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Sonendo, Inc.'s revenue has shown modest growth of 4% over the 5-year period. The most recent EPS of $-129.63 indicates the company is currently unprofitable.
SONX Revenue Growth, EPS Growth & YoY Performance
SONX Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2024 | $8.0M | -$6.8M | $-15.77 |
| Q2 2024 | $8.3M | -$6.8M | $-0.08 |
| Q1 2024 | $7.0M | -$6.8M | $-0.07 |
| Q3 2023 | $9.8M | -$15.1M | $-0.18 |
| Q2 2023 | $10.5M | -$15.1M | $-0.19 |
| Q1 2023 | $9.0M | -$15.4M | $-0.16 |
| Q3 2022 | $7.9M | -$10.9M | $-0.47 |
| Q2 2022 | $8.0M | -$10.9M | $-0.57 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Sonendo, Inc. Dividends, Buybacks & Capital Allocation
SONX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Sonendo, Inc. (CIK: 0001407973)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SONX
What is the AI rating for SONX?
Sonendo, Inc. (SONX) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SONX's key strengths?
Claude: Gross margin of 35.7% indicates underlying product viability and market demand. Revenue growth of 4.7% YoY demonstrates continued customer adoption despite losses.
What are the risks of investing in SONX?
Claude: Operating losses of $29.4M on $33.2M revenue reveal severe operational inefficiency and unsustainable cost structure. Negative operating cash flow of -$24.7M with estimated 5-month cash runway at current burn rate.
What is SONX's revenue and growth?
Sonendo, Inc. reported revenue of $33.2M.
Does SONX pay dividends?
Sonendo, Inc. does not currently pay dividends.
Where can I find SONX SEC filings?
Official SEC filings for Sonendo, Inc. (CIK: 0001407973) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SONX's EPS?
Sonendo, Inc. has a diluted EPS of $-59.03.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is SONX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Sonendo, Inc. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is SONX stock overvalued or undervalued?
Valuation metrics for SONX: ROE of -540.0% (sector avg: 15%), net margin of -84.4% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy SONX stock in 2026?
Our dual AI analysis gives Sonendo, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SONX's free cash flow?
Sonendo, Inc.'s operating cash flow is $-24.7M, with capital expenditures of $161.0K. FCF margin is -74.7%.
How does SONX compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -84.4% (avg: 12%), ROE -540.0% (avg: 15%), current ratio 1.39 (avg: 2).
Is Sonendo, Inc. carrying too much debt?
SONX has a debt-to-equity ratio of 2.78x, which is above the Healthcare sector average of 0.6x. However, the current ratio of 1.39 suggests adequate short-term liquidity.